Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 26, 2010

Premium

Vance Vanier will take over the president and CEO positions at Navigenics.

Vanier started at Navigenics in 2008 and was serving as chief medical officer of the consumer genomics firm. Before joining Navigenics, he was a partner at Mohr Davidow Ventures. He also is a clinical faculty member at Stanford University Medical Center.


Complete Genomics said recently that Aaron Solomon joined the firm as vice president of business development.

Solomon was vice president of business development at Tethys Biosciences. Prior to that, he held positions in sales, marketing, and business development at Incyte, ParAllele, and Affymetrix. He graduated from the University of California, Irvine, with a BS in biological sciences.


Mark McGowan has joined CombiMatrix's board of directors. McGowan is the managing member of SAF Capital Management. Prior to forming that investment firm, he was cofounder and managing partner of MPG Capital Management.

McGowan previously worked within the consumer and market knowledge function of Procter & Gamble. He holds a BS in microbiology with a focus in genomics and molecular genetics from Michigan State University.


Michael Hayden has joined MedBiogene's board of directors. He is a professor of medical genetics at the University of British Columbia as well as the director of the Center for Molecular Medicine and Therapeutics in Vancouver, the Canadian firm said last week.

Hayden was a founder, director, and chief medical adviser of Aspreva Pharmaceuticals. He is also a director and chief scientific officer of Xenon Pharmaceuticals.

Hayden holds an MD and PhD from the University of Cape Town, completed a postdoc at Harvard Medical School, and is a fellow of the Royal College of Physicians and Surgeons of Canada.


SQI Diagnostics has named Yehuda Shoenfeld to be chairman of its scientific advisory board.

Shoenfeld is head of the department of medicine and the Center for Autoimmune Diseases at Sheba Medical Center, and is chair for research of autoimmune diseases at Tel-Aviv University in Israel.


RTS Life Science has named Richard Carpenter as its mid-Atlantic sales manager in the US. Prior to joining Manchester, UK-based RTS, Carpenter worked for LabCyte and Tecan.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.